trovafloxacin has been researched along with Experimental Pneumococcal Meningitis in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hickey, SM; McCracken, GH; París, MM; Shelton, S; Trujillo, M | 1 |
Chow, LL; Kim, YS; Liu, Q; Täuber, MG | 1 |
Brück, W; Fischer, FR; Nau, R; Schmidt, H; Stringaris, AK; Stuertz, K; Zysk, G | 1 |
Gootz, TD; Klugman, KP | 1 |
Cottagnoud, M; Cottagnoud, P; Gerber, CM; Hänni, F; Neftel, K; Rodoni, D; Täuber, MG | 1 |
Bastero, R; Friedland, IR; Jafri, HS; Lutsar, I; McCoig, CC; McCracken, GH; Olsen, K; Shelton, S; Wubbel, L | 1 |
Eiffert, H; Mäder, M; Nau, R; Schmidt, H; Stuertz, K; Trostdorf, F | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Neftel, K; Täuber, MG | 1 |
McCracken, GH | 1 |
1 review(s) available for trovafloxacin and Experimental Pneumococcal Meningitis
Article | Year |
---|---|
Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Vancomycin | 2000 |
8 other study(ies) available for trovafloxacin and Experimental Pneumococcal Meningitis
Article | Year |
---|---|
Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporin Resistance; Colony Count, Microbial; Dexamethasone; Drug Evaluation; Drug Therapy, Combination; Fluoroquinolones; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Vancomycin | 1995 |
Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Rifampin; Streptococcus pneumoniae | 1997 |
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Topics: Adult; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Humans; Injections, Intravenous; Interleukin-1; Lactic Acid; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 1997 |
In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Hydrogen-Ion Concentration; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumonia, Pneumococcal; Rabbits; Streptococcus pneumoniae | 1997 |
Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin | 1999 |
Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cerebrospinal Fluid; Disease Models, Animal; Fluoroquinolones; Half-Life; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae | 1999 |
Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Immunoenzyme Techniques; Lipopolysaccharides; Meningitis, Pneumococcal; Moxifloxacin; Naphthyridines; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Values; Rifabutin; Teichoic Acids; Virginiamycin | 1999 |
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2000 |